VERVE-102 is an experimental one-time gene-editing therapy that significantly lowered bad LDL cholesterol levels in early ...

Scientists recently slashed high cholesterol levels by 62 percent.

A new gene-editing therapy could revolutionize the treatment for high cholesterol, all in one dose.

Add Yahoo as a preferred source to see more of our stories on Google. Regulating cholesterol levels is crucial for heart health. There are two types of cholesterol (we’ll explain the difference ...

An experimental gene-editing therapy that aims to lower bad cholesterol for the long-term after a single infusion is off to a ...

Fiber, antioxidants, and other nutrients found in whole grains can help support healthy cholesterol levels and heart health ...

We’re putting the decades-long debate to rest.

LDL cholesterol, often called “bad” cholesterol, is significant in heart health. It’s a waxy substance in the blood that can accumulate in artery walls, forming plaque. This plaque buildup, known as ...

Drugmaker Eli Lilly is testing a new experimental drug that could be a game changer in treating high cholesterol, it said.

One and done? Pharma giant Eli Lilly announced Monday that its gene-editing therapy can reduce LDL (“bad”) cholesterol by up ...

People with low levels of low-density lipoprotein cholesterol (LDL-C) in their blood have a lower risk of dementia, including lower risk of Alzheimer’s disease related dementia, shows a study ...

People with low levels of low-density lipoprotein cholesterol (LDL-C) in their blood have a lower risk of dementia, including lower risk of Alzheimer's disease related dementia, shows a study ...